SEC Comment Letter for NORTHWEST BIOTHERAPEUTICS INC (NWBO) (CIK 0001072379) (NWBO) — Jul 29, 2009

NORTHWEST BIOTHERAPEUTICS INC (NWBO) (CIK 0001072379)
Date: July 29, 2009 · CIK: 0001072379 · Accession: 0000000000-09-040701

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 000-33393

Date

July 29, 2009

Author

Jeffrey Riedler, Assistant Director

Form

UPLOAD

Company

NORTHWEST BIOTHERAPEUTICS INC (NWBO) (CIK 0001072379)

Letter

Mail Stop 4720 July 29, 2009 Alton L. Boynton, Ph.D President and Chief Executive Officer Northwest Biotherapeutics, Inc. 7600 Wisconsin Avenue, Suite 750 Bethesda, Maryland 20814 Re: Northwest Biotherapeutics, Inc. Preliminary Proxy Statement on Form PRE14A Filed July 14, 2009 File No. 000-33393

Dear Mr. Boynton: We have completed our review of your Preliminary Proxy Statement on Form PRE14A and related filings and have no further comments at this time.

Sincerely,
Jeffrey Riedler, Assistant Director

Show Raw Text

Mail Stop 4720
July 29, 2009
        Alton L. Boynton, Ph.D     President and Chief Executive Officer Northwest Biotherapeutics, Inc. 7600 Wisconsin Avenue, Suite 750 Bethesda, Maryland 20814
Re: Northwest Biotherapeutics, Inc.
 Preliminary Proxy Statement on Form PRE14A
  Filed July 14, 2009    File No. 000-33393

Dear Mr. Boynton:    We have completed our review of your Preliminary Proxy Statement on Form PRE14A and related filings and have no further comments at this time.

Sincerely,

Jeffrey Riedler,  Assistant Director

SecProbe.io